Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Sesame Care vs VivioMD

Sesame Care
Site position #2

Higher grade

vs+30.4
VivioMD
Site position #450

Lower grade

The verdict

Sesame Care takes it — 87.8/100 to 57.4/100.

Sesame Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSesame Care +39
84
45
Dose & formulationSesame Care +16
92
76
Clinical oversightSesame Care +39
94
55
Labs & monitoringSesame Care +31
84
53
FulfillmentVivioMD +1
80
81
Contract termsSesame Care +63
92
29
Sesame Care · left barVivioMD · right bar

The numbers

MetricSesame CareVivioMD
WeighScore87.8/10057.4/100
GradeB+C
Site position#2#450
SemaglutideBrand Wegovy pill from $149/mo at 1.5 and 4 mg only, $299/mo at 9 and 25 mg — plus Sesame care: $59/mo only on the 12-month prepay, otherwise $99 billed every 28 days (13 charges a year)GLP-1 injection advertised from $299/mo; confirm formulation
TirzepatideBrand Zepbound vial $299/mo (2.5 mg), $399 (5 mg), $449 (7.5–15 mg); KwikPen $299 / $399 / $499 / $699 (10–15 mg) — plus Sesame care: $59/mo on the 12-month prepay, otherwise $99 per 28 daysGLP-1+GIP injection advertised from $398/mo; confirm formulation
CoverageNationwide marketplaceTerms exclude Louisiana; homepage says all 50 states
Brand-name accessYesYes
Oral / sublingualYesYes
Sesame Care

Site position #2 · B+

Strengths

  • Real FDA-approved brand-name access — Wegovy pen and pill, Zepbound, Ozempic, Mounjaro and Rybelsus
  • Established platform (operating since 2018) with LegitScript, BBB accreditation and large third-party review volume
  • You choose the provider and see the price up front — genuine marketplace transparency
  • Oral routes available (Wegovy pill, Rybelsus)

Where it loses points

  • A generalist marketplace, not a dedicated weight-loss program — lighter ongoing hand-holding than a specialist desk
  • Two-part cost (a platform subscription plus the medication) makes the true monthly total harder to compare
  • Brand-name cash prices can run high without insurance
VivioMD

Site position #450 · C

FDAWarning letter issued to VivioMD Group LLC dba VivioMD in June 2026. See the FDA warning-letter database.

Strengths

  • Advertises GLP-1 tablets and injections plus branded Ozempic
  • Terms identify OpenLoop clinical groups and RedRock, Health Warehouse and Triad Rx pharmacies
  • Refund policy describes refunds for unused prepaid months without medication shipments

Where it loses points

  • Terms exclude Louisiana despite nationwide homepage language
  • Cancellation requests must arrive at least 72 hours before the next bill
  • Headline GLP-1 product names do not specify the exact compounded formulation
  • Compounded medications are not FDA-approved

Featured provider

Sesame Care

Sesame Care scores 87.8/100 (B+). An established national telehealth marketplace with the widest real brand-name GLP-1 access in the ranking — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard